New drug aims to reverse wasting in cancer patients
NCT ID NCT07530666
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new medicine called DS010 in 58 adults with cancer who are losing weight and muscle (cachexia). The goal is to see if it is safe and can help patients gain weight and improve muscle mass. The trial has two parts: first finding a safe dose, then checking how well it works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CACHEXIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?